Contents
On this page
- Contributions of pooling
- Derivation of the pooled estimate
- Historical adoption of meta-analysis
- Heterogeneity as a finding
- Dependence of statistical significance on the choice of method
- Circumstances in which pooling misleads
- Reporting a pooled estimate for correct interpretation
- Circumstances in which pooling is inappropriate
- Key points
- Application to your study
- Frequently asked questions
Academy · Research Data Analytics & AI · Importance of meta-analysis
The Importance of Meta-Analysis in Medical Research: Contributions and Limitations
Pooling does not create evidence. It provides precision, power and an explicit account of the extent to which studies disagree, but only when the studies estimate a sufficiently similar quantity for averaging to be meaningful. The same dataset may reach or fail to reach statistical significance depending on the confidence-interval method selected, which indicates the limited weight a pooled p-value can bear.
Meta-analysis changed from an uncommon technique to a default approach in approximately fifteen years, and this default has costs. The relevant question is not whether to pool but what pooling adds to the findings of the individual studies. The answer is narrow but valuable: a weighted average with a smaller standard error, a formal statement of between-study variability, and a framework for investigating why studies differ. Pooling does not add validity. A pooled estimate inherits every bias in its component studies and conceals them behind a narrower interval.
Learning objectives
- The contribution of a meta-analysis beyond the individual studies, and its limitations
- The operation of inverse-variance weighting, and the reasons a single study may account for a quarter of the result
- The reasons a pooled estimate may be statistically significant under one confidence-interval method and not under another
- The interpretation of a random-effects summary without overinterpretation
- The circumstances in which the appropriate decision is to describe the studies rather than pool them
- The checks for small-study effects that are informative and those that are so underpowered as to be misleading
Common misconceptions
- “A larger number of studies yields a more reliable answer.” A larger number of studies yields a narrower interval. If the studies share a bias, pooling makes a biased estimate appear more certain.
- “A pooled result resolves the question.” LeLorier and colleagues, in the New England Journal of Medicine, compared meta-analyses with the large randomised trials that followed them and documented substantive discrepancies in both directions.
- “The statistical significance of the pooled effect is a property of the data.” Across 920 Cochrane meta-analyses, 45% were significant under the Wald-type normal method and 35% under the Hartung-Knapp-Sidik-Jonkman method, using the same data with a different method.
- “A funnel plot test can determine whether publication bias is present.” Sterne and colleagues, in the BMJ, advise against these tests when fewer than 10 studies are available, and state that the practical minimum is substantially higher when heterogeneity is substantial.
- “The random-effects summary represents the average effect in practice.” Riley and colleagues, also in the BMJ, argue it is an estimate of the mean of a distribution of effects, and that the distribution is the clinically relevant object.
Contributions of pooling
Cochrane’s training materials state the reasons for conducting a meta-analysis explicitly: increased precision, increased statistical power, quantification of effects and their uncertainty, exploration of between-study differences, and resolution of controversies arising from apparently conflicting studies 2. It is instructive to consider what the list includes and what it omits. Precision and power are genuine statistical gains. Quantification and exploration are descriptive gains and are often the most valuable part of the exercise, because they require the reviewer to state the extent of disagreement between studies rather than leave it implicit in a narrative.
Validity is absent from the list. Pooling cannot correct a shared design flaw. If every trial in a set used an unblinded outcome assessor, the pooled estimate is a precise measurement of a biased quantity 7. For this reason, the synthesis step cannot be separated from the appraisal step, and a systematic review that extracts effect sizes without extracting risk-of-bias information cannot determine what its own summary means.
The last of Cochrane’s five reasons, the resolution of controversies, should be treated with the greatest caution. Pooling can show that an apparent conflict results from imprecision in small studies, which genuinely resolves it. It can equally obscure a real difference between populations by averaging it, which has the opposite effect 8.
The contribution of each stated reason for pooling
| Stated reason | What you get | What it does not provide |
|---|---|---|
| Increased precision | A narrower confidence interval on the summary effect | Any correction for bias shared across the included studies |
| Increased statistical power | Ability to detect an effect too small for individual studies | Protection against detecting a bias rather than a true effect |
| Quantification of effects and uncertainty | An effect size on a stated scale with an interval | A statement of the applicability of that effect to a particular setting, unless a prediction interval is also given |
| Exploration of between-study differences | An explicit estimate of the extent to which true effects vary | A causal explanation of why they vary; subgroup comparisons remain observational |
| Settling controversies | Resolution where the conflict was imprecision in small studies | Resolution where the conflict reflects a genuine difference between populations |
Reasons as listed in Cochrane training materials on meta-analysis (Cumpston, compiler; Hopewell, Higgins, Cochrane Statistical Methods Group and Cochrane Netherlands, source materials). The right-hand column states the limitations described in the methodological sources cited in this article.
Derivation of the pooled estimate
A meta-analysis is a weighted average, and under inverse-variance weighting each study’s weight is one divided by the square of its standard error 26. The consequence should be stated explicitly: studies are weighted according to the precision with which they measured the effect, not according to their size, recency, quality or relevance. Precision depends on sample size and event rate, so in most clinical sets the weighting approximates a sample-size weighting, with all the consequences that implies.
The worked caffeine example in Cochrane’s training materials illustrates the distribution: seven studies, with weights ranging from 2.9% to 26.4% and summing to 100% 2. One study contributes more than a quarter of the result and another less than a thirtieth. Without examining the weight column of a forest plot, the reviewer cannot know whose result is being reported. A sensitivity analysis that removes the most heavily weighted study is therefore not an optional refinement but the minimum check that the conclusion reflects the literature rather than a single trial.
At this point, the arithmetic depends on the extraction sheet. A standard error that was mis-transcribed, or reconstructed from a confidence interval on the wrong scale, changes a study’s weight as well as its position, which is why quantitative data extraction requires more care than it usually receives 3,5.
Historical adoption of meta-analysis
The method predates its widespread use. Cochran, in Biometrics in 1954, set out the statistical problem of combining estimates from different experiments 26. However, when DerSimonian and Laird searched the first ten 1982 issues of four weekly medical journals, they found exactly one article out of 589 that used formal statistical methods to combine results across studies 25. Their own paper re-analysed eight published clinical reviews, with the number of randomised trials per review ranging from 5 to 26. These are small sets by current standards, which indicates that the random-effects model was developed for precisely the situation in which most reviewers find themselves 25.
Egger and Davey Smith, writing in the BMJ in 1997, documented the sharp rise in publications on meta-analysis across the decade from 1987 to 1996 20. During that decade, the method became an expectation rather than an innovation, and the methodological literature has since been responding to the practice. Most of the cautions described in this article were published after the method had already become standard.
Heterogeneity as a finding
Between-study variation is usually presented as an obstacle to pooling, but it is more appropriately regarded as one of the outputs. Higgins and Thompson, in Statistics in Medicine, proposed describing heterogeneity in a manner independent of the effect metric and the number of studies, precisely because the quantity of interest is the extent to which true effects differ, not the extent to which the test statistic exceeds its degrees of freedom 14.
The practical implication, as argued by Riley and colleagues in the BMJ, is that a random-effects meta-analysis estimates the mean of a distribution of effects, and that reporting only that mean discards the information clinicians need 8,11. If effects genuinely vary across settings, the spread of that distribution indicates the effect to be expected in a given patient population, and a prediction interval states it directly. A pooled mean with a narrow confidence interval and a wide prediction interval is not contradictory; it is a precise estimate of an average that may not apply to any particular population.
Borenstein and Higgins, in Prevention Science, make the related point regarding subgroups: comparing subgroup summaries is a between-study comparison, with the observational character that implies, even when every included study is randomised 6.
Dependence of statistical significance on the choice of method
The clearest demonstration that a pooled p-value depends on the analysis as well as the data is provided by Veroniki and colleagues’ review of methods for calculating uncertainty in the random-effects summary effect. Across 920 Cochrane meta-analyses, 45% were statistically significant using the Wald-type normal method and 35% using the Hartung-Knapp-Sidik-Jonkman method 27. The data were identical. One in ten of those results changed significance status as a consequence of a choice that most published reviews do not report 27.
Two implications follow. The first is procedural: the confidence-interval method should be specified in the protocol and the methods section before the data are seen, and the methodology walkthrough describes how to specify it. The second is interpretive: if a result lies so close to the conventional threshold that the method determines its significance, the appropriate report is the estimate and its interval rather than a verdict. Greenland and colleagues, in the European Journal of Epidemiology, catalogue the misinterpretations that arise from treating that threshold as a finding, and most of them apply with greater force to a pooled estimate than to a single trial, because the pooled interval appears authoritative 4.
The proportion of pooled results reaching statistical significance, by confidence-interval method, across the same set of meta-analyses. Source: Veroniki AA, Jackson D, Bender R, Kuss O, Langan D, Higgins JPT, Knapp G, Salanti G. Methods to calculate uncertainty in the estimated overall effect size from a random-effects meta-analysis.
Circumstances in which pooling misleads
Three failure modes recur. The first is pooling across a substantive difference, such as different populations, comparators or outcome definitions, so that the summary describes an intervention that was not delivered to any actual patient group. This is a judgement made at the eligibility stage rather than a statistical problem, and no diagnostic test will detect it.
The second is the shared bias described above: a precise average of studies that are biased in the same direction. The work of Wood and colleagues in the BMJ on the relationship between design features and estimated effects is the reason risk-of-bias assessment precedes synthesis rather than accompanying it 7.
The third is small-study effects, which the funnel plot was designed to display. The test of Egger and colleagues in the BMJ remains widely used, but the later recommendations of Sterne and colleagues in the same journal constitute the operative guidance: these tests should generally not be used when fewer than 10 studies are pooled, and the minimum may be substantially higher when heterogeneity is substantial 9. Most clinical meta-analyses fall below that threshold. Conducting the test regardless and reporting a non-significant result as evidence of no publication bias is among the most common avoidable errors in the literature, and the comparison by LeLorier and colleagues in the New England Journal of Medicine of meta-analyses with the large trials that followed them indicates that the pooled answer is provisional 19.
Reporting a pooled estimate for correct interpretation
Most misinterpretation of meta-analyses arises from a single sentence: the sentence in the abstract that reports the summary effect. The problem is rarely dishonesty. Rather, a single point estimate with a confidence interval conveys no information about the extent of disagreement between studies, the method by which the interval was calculated or the proportion of the weight contributed by one trial. All three affect the conclusions a reader should draw, and all three can be stated in the same sentence.
The same pooled result, reported in two ways
Invites over-reading
Meta-analysis of the included trials showed a significant benefit of the intervention (p<0.05), with substantial heterogeneity between studies.
Significant by which method? Across 920 Cochrane meta-analyses, 45% were significant under a Wald-type interval and 35% under Hartung-Knapp-Sidik-Jonkman. The reader cannot determine on which side of that difference this result lies.
Whose result is this? No weights are reported, so a conclusion driven by one trial cannot be distinguished from a consistent finding across seven.
“Substantial heterogeneity” and a significant mean, together? If true effects vary, the mean may apply to no real population, and the extent of the variation is not stated.
Timing of the method choice. It is not stated whether the method was chosen before or after the data were seen, so a pre-specified choice cannot be distinguished from a data-driven decision.
States what was estimated
Seven trials were pooled using a random-effects model with inverse-variance weighting; weights ranged from 2.9% to 26.4%, so one trial contributed just over a quarter of the summary estimate. Between-study variance was estimated and reported alongside a prediction interval, and the confidence interval was calculated by the Hartung-Knapp-Sidik-Jonkman method as pre-specified in the protocol; a Wald-type interval is given in the appendix for comparison. Excluding the heaviest-weighted trial did not change the direction of the estimate.
The interval method is named and pre-specified, so the reader need not infer whether significance is an artefact of method.
The weight range discloses the dependence on a single trial without the reader having to ask.
A prediction interval reported alongside the mean addresses the question of most relevance to clinicians.
The leave-one-out analysis is reported irrespective of whether it changed the result, which makes it informative.
Neither version claims more than the data support; the second states which data were used, under which method, and the distribution of the weight. It is three sentences longer and eliminates the three most common sources of overinterpretation of a pooled estimate.
Circumstances in which pooling is inappropriate
A review that does not produce a pooled estimate is not a failed review. It is the correct output when the included studies measure different quantities, when there are too few studies to estimate between-study variance reliably, or when the risk of bias differs so greatly across studies that an average would be meaningless. The decision should be stated explicitly and the studies described instead, in a structured and tabulated form, with the direction and magnitude of each result and an explanation of why they were not combined.
The decision is easier to defend if it was anticipated. A protocol that states the conditions under which pooling will and will not be attempted converts a judgement at the analysis stage into a pre-specified rule, which also distinguishes a defensible review from one that appears to have selected the analysis that yielded a result. The Pubrica meta-analysis service page describes how such pre-specification is usually structured, and biostatistics support is the stage at which the model and estimator choices are usually determined.
Key points
Key points
Meta-analysis provides precision, power and an explicit account of disagreement between studies. It does not confer validity, and it cannot correct a bias shared by the included studies. Under inverse-variance weighting, precision rather than quality or relevance determines which results dominate; in Cochrane’s worked caffeine example, weights ranged from 2.9% to 26.4% across seven studies. Statistical significance is itself partly a consequence of method choice: across 920 Cochrane meta-analyses, 45% were significant under a Wald-type interval and 35% under Hartung-Knapp-Sidik-Jonkman. Authors should report the weights, the between-study variation and the interval method, and should regard a decision not to pool as a legitimate result.
Application to your study
Application to your study
- Examine the weight column before the point estimate. If one study carries a quarter or more of the weight, the conclusion relates principally to that study and should state this.
- Specify the confidence-interval method in the protocol rather than the manuscript. One in ten pooled results in the Cochrane set changed significance status between two reasonable methods.
- Report a prediction interval wherever between-study variance is non-trivial. The mean of a distribution of effects is not the effect a clinician should expect.
- Conduct a leave-one-out analysis and report it irrespective of its effect on the results. A sensitivity analysis reported only when it is reassuring does not fulfil the purpose of a sensitivity analysis.
- Do not conduct a funnel plot asymmetry test with fewer than 10 studies. Non-significance of such a test should not be reported as evidence against small-study effects, irrespective of the number of studies.
- Confirm that every pooled study estimates the same quantity. The studies should share the comparator, outcome definition and timing of measurement. Where they differ, the difference defines a subgroup or constitutes a reason not to pool.
- Specify the conditions for not pooling in advance. A pre-specified rule stating when studies will be described rather than combined distinguishes a principled judgement from a post hoc choice.
Frequently asked questions
Precision and power, together with an explicit estimate of the extent of disagreement between studies. Cochrane’s training materials list five reasons: increased precision, increased statistical power, quantification of effects and their uncertainty, exploration of between-study differences, and resolution of controversies. The first two are statistical gains; the third and fourth are frequently undervalued by reviewers, because they convert an impression that “the literature is mixed” into a quantitative estimate. Pooling does not add validity. A weighted average of biased studies is a precise estimate of a biased quantity, which is why risk-of-bias assessment must precede synthesis rather than accompany it.
Under inverse-variance weighting, each study’s weight is one divided by the square of its standard error. In practice, studies are therefore weighted by the precision with which they measured the effect, which depends largely on sample size and event rate, and not by quality, recency or relevance to the review question. The distribution can be highly uneven. Cochrane’s worked caffeine example pools seven studies with weights from 2.9% to 26.4%, so a single study contributes more than a quarter of the result. The weight column should always be examined, because it indicates whose findings the summary estimate predominantly reflects.
Yes, in two distinct ways. If the included studies share a bias, correct pooling produces a precise estimate of the wrong quantity, and no statistical output will indicate this. If the studies estimate genuinely different effects, the summary mean may describe a situation that applies to no real population. LeLorier and colleagues, in the New England Journal of Medicine, compared published meta-analyses with the large randomised trials that followed and found substantive discrepancies in both directions. A pooled estimate is the best current summary of a body of evidence, not a definitive answer to the question.
In some cases, decisively. Veroniki and colleagues examined 920 Cochrane meta-analyses and found 45% statistically significant under the Wald-type normal method compared with 35% under the Hartung-Knapp-Sidik-Jonkman method, using identical data with a different interval calculation. Approximately one in ten results therefore had a significance status determined by an analytic choice that most reviews do not report. The appropriate response is to pre-specify the interval method in the protocol, to report the method used and, where a result lies near the conventional threshold, to report the estimate and interval rather than a verdict.
There is no clear threshold, and the sources are more informative on specific procedures than on the general question. DerSimonian and Laird developed the random-effects model using eight re-analysed reviews containing between 5 and 26 trials each, so small sets were always within its scope. Testing for funnel plot asymmetry does have a stated minimum: Sterne and colleagues advise against it with fewer than 10 studies, and state that the minimum may be substantially higher under substantial heterogeneity. Between-study variance is also poorly estimated from few studies, which is why the interval method is most consequential precisely where sets are smallest.
Not in itself, and treating it as a decision rule is an inappropriate framing. Higgins and Thompson, in Statistics in Medicine, proposed describing heterogeneity in a manner independent of the effect metric and the number of studies, because the relevant question is the extent to which true effects differ rather than whether a test crosses a threshold. Riley and colleagues argue that the appropriate response is usually to report a prediction interval alongside the mean. The valid reasons not to pool are clinical and definitional: different comparators, outcome definitions or populations. These are determined at the eligibility stage, not from a heterogeneity statistic.
Authors should state that the studies were not pooled, explain the reason with reference to the studies rather than the statistics, and then undertake the descriptive synthesis rigorously: tabulating each study’s design, population, comparator, outcome definition and result with its interval, and stating the direction of the evidence without producing a figure that implies greater certainty than the data permit. The decision is considerably more defensible if the protocol had already set out the conditions under which pooling would not be attempted. A review that explains why an average would be meaningless is more useful than one that produces an average that should not be used.
References
- Hooper L, Abdelhamid A, Bunn D, Brown T, Summerbell CD, Skeaff CM. Effects of total fat intake on body weight. Cochrane Database of Systematic Reviews. 2015:CD011834. doi:10.1002/14651858.CD011834 read 9 October 2026. doi.org/10.1002/14651858.CD011834
- Cumpston M (comp.); Hopewell S, Higgins JPT, Cochrane Statistical Methods Group, Cochrane Netherlands (source materials). Introduction to meta-analysis: Cochrane training presentation (not the Borenstein textbook of the same name). Cochrane training materials. read 9 October 2026. cochrane.org
- Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Statistical Methods in Medical Research. 2018;27:1785-1805. doi:10.1177/0962280216669183 read 9 October 2026. doi.org/10.1177/0962280216669183
- Greenland S, Senn SJ, Rothman KJ, Carlin JB, Poole C, Goodman SN, Altman DG. Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations. European Journal of Epidemiology. 2016;31:337-350. doi:10.1007/s10654-016-0149-3 read 9 October 2026. doi.org/10.1007/s10654-016-0149-3
- Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Medical Research Methodology. 2014;14:135. doi:10.1186/1471-2288-14-135 read 9 October 2026. doi.org/10.1186/1471-2288-14-135
- Borenstein M, Higgins JPT. Meta-analysis and subgroups. Prevention Science. 2013;14:134-143. doi:10.1007/s11121-013-0377-7 read 9 October 2026. doi.org/10.1007/s11121-013-0377-7
- Savovic J, Jones HE, Altman DG, Harris RJ, Juni P, Pildal J, Als-Nielsen B, Balk EM, Gluud C, Gluud LL, Ioannidis JPA, Schulz KF, Beynon R, Welton NJ, Wood L, Moher D, Deeks JJ, Sterne JAC. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Annals of Internal Medicine. 2012;157(6):429-438. doi:10.7326/0003-4819-157-6-201209180-00537 read 9 October 2026. doi.org/10.7326/0003-4819-157-6-201209180-00537
- Riley RD, Higgins JPT, Deeks JJ. Interpretation of random effects meta-analyses. BMJ. 2011;342:d549. doi:10.1136/bmj.d549 read 9 October 2026. doi.org/10.1136/bmj.d549
- Sterne JAC, Sutton AJ, Ioannidis JPA, Terrin N, Jones DR, Lau J, Carpenter J, Rucker G, Harbord RM, Schmid CH, Tetzlaff J, Deeks JJ, Peters J, Macaskill P, Schwarzer G, Duval S, Altman DG, Moher D, Higgins JPT. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002. doi:10.1136/bmj.d4002 read 9 October 2026. doi.org/10.1136/bmj.d4002
- Viechtbauer W. Conducting meta-analyses in R with the metafor package. Journal of Statistical Software. 2010;36(3):1-48. doi:10.18637/jss.v036.i03 read 9 October 2026. doi.org/10.18637/jss.v036.i03
- Higgins JPT, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. Journal of the Royal Statistical Society: Series A. 2009;172(1):137-159. read 9 October 2026. discovery-pp.ucl.ac.uk
- Leeflang MMG, Deeks JJ, Gatsonis C, Bossuyt PMM; Cochrane Diagnostic Test Accuracy Working Group. Systematic reviews of diagnostic test accuracy. Annals of Internal Medicine. 2008;149(12):889-897. doi:10.7326/0003-4819-149-12-200812160-00008 read 9 October 2026. doi.org/10.7326/0003-4819-149-12-200812160-00008
- Leandro G. Meta-analysis in medical research. Blackwell Publishing / BMJ Books (book). 2005. read 9 October 2026. link.springer.com
- Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine. 2002;21(11):1539-1558. doi:10.1002/sim.1186 read 9 October 2026. doi.org/10.1002/sim.1186
- Haynes RB. Of studies, syntheses, synopses, and systems: the 4S evolution of services for finding current best evidence. ACP Journal Club. 2001;134:A11-A13. read 9 October 2026. bmcmededuc.biomedcentral.com
- Glasziou P, Irwig L, Bain C, Colditz G. Systematic reviews in health care: a practical guide. Cambridge University Press (book). 2001. read 9 October 2026. link.springer.com
- Egger M, Davey Smith G, Altman DG. Systematic reviews in health care: meta-analysis in context. BMJ Books (book). 2001. read 9 October 2026. link.springer.com
- Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F. Methods for meta-analysis in medical research. Wiley (book). 2000. read 9 October 2026. link.springer.com
- LeLorier J, Gregoire G, Benhaddad A, Lapierre J, Derderian F. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. New England Journal of Medicine. 1997;337:536-542. read 9 October 2026. arxiv.org
- Egger M, Davey Smith G. Meta-analysis: potentials and promise. BMJ. 1997;315(7119):1371-1374. doi:10.1136/bmj.315.7119.1371 read 9 October 2026. doi.org/10.1136/bmj.315.7119.1371
- Sackett DL, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. BMJ. 1996;312(7023):71-72. doi:10.1136/bmj.312.7023.71 read 9 October 2026. doi.org/10.1136/bmj.312.7023.71
- Eysenck HJ. Meta-analysis and its problems. BMJ. 1994;309:789-792. read 9 October 2026. link.springer.com
- Pagliaro L, D'Amico G, Sorensen TI, Lebrec D, Burroughs AK, Morabito A, Tine F, Politi F, Traina M. Prevention of first bleeding in cirrhosis: a meta-analysis of randomized trials of nonsurgical treatment. Annals of Internal Medicine. 1992;117(1):59-70. read 9 October 2026. link.springer.com
- Teo KK, Yusuf S, Collins R, Held PH, Peto R. Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials. BMJ. 1991;303(6816):1499-1503. read 9 October 2026. link.springer.com
- DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials. 1986;7(3):177-188. doi:10.1016/0197-2456(86)90046-2 read 9 October 2026. doi.org/10.1016/0197-2456(86)90046-2
- Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10(1):101-129. doi:10.2307/3001666 read 9 October 2026. doi.org/10.2307/3001666
- Veroniki AA, Jackson D, Bender R, Kuss O, Langan D, Higgins JPT, Knapp G, Salanti G. Methods to calculate uncertainty in the estimated overall effect size from a random-effects meta-analysis. doi:10.1002/jrsm.1319 read 9 October 2026. doi.org/10.1002/jrsm.1319
Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.
How to cite this article
Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.
Pubrica Academy. (2026, October 9). The Importance of Meta-Analysis in Medical Research: Contributions and Limitations. Pubrica. https://pubrica.com/academy/medical-writing/importance-of-meta-analysis-in-medical-research/
Pubrica Academy. “The Importance of Meta-Analysis in Medical Research: Contributions and Limitations.” Pubrica, 9 Oct. 2026, pubrica.com/academy/medical-writing/importance-of-meta-analysis-in-medical-research/.
Pubrica Academy (2026) The Importance of Meta-Analysis in Medical Research: Contributions and Limitations. Pubrica. Available at: https://pubrica.com/academy/medical-writing/importance-of-meta-analysis-in-medical-research/ (Accessed: 15 October 2026).
Pubrica Academy. “The Importance of Meta-Analysis in Medical Research: Contributions and Limitations.” Pubrica. October 9, 2026. https://pubrica.com/academy/medical-writing/importance-of-meta-analysis-in-medical-research/
Pubrica Academy, ‘The Importance of Meta-Analysis in Medical Research: Contributions and Limitations’ (Pubrica, 9 October 2026) <https://pubrica.com/academy/medical-writing/importance-of-meta-analysis-in-medical-research/> accessed 15 October 2026.
Pubrica Academy. The Importance of Meta-Analysis in Medical Research: Contributions and Limitations. [Internet]. Pubrica; 2026 Oct 9 [cited 2026 Oct 15]. Available from: https://pubrica.com/academy/medical-writing/importance-of-meta-analysis-in-medical-research/
Pubrica Academy, “The Importance of Meta-Analysis in Medical Research: Contributions and Limitations,” Pubrica, Oct. 9, 2026. [Online]. Available: https://pubrica.com/academy/medical-writing/importance-of-meta-analysis-in-medical-research/
@misc{importance_of_meta_analysis_in_medical_2026,
author = {{Pubrica Academy}},
title = {The Importance of Meta-Analysis in Medical Research: Contributions and Limitations},
howpublished = {Pubrica},
year = {2026},
month = {oct},
url = {https://pubrica.com/academy/medical-writing/importance-of-meta-analysis-in-medical-research/},
note = {Accessed: <span data-cite-acc="iso">2026-10-15</span>}
}This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.
Assessing whether studies should be pooled: a pre-analysis checklist
Each item should be answered in writing before the model is run, and the answers retained, since most belong verbatim in the methods section. Items that cannot be answered are those a methods reviewer is likely to raise.
POOLING DECISION RECORD
Review: ______________________ Outcome: ______________________
1. ARE THESE STUDIES ESTIMATING THE SAME QUANTITY?
[ ] Same intervention, at a comparable dose/intensity
[ ] Same comparator (note any placebo vs active mix)
[ ] Same outcome construct AND same measurement scale
[ ] Same measurement timing, or timing handled explicitly
[ ] Populations close enough that one average is meaningful
If any box is unticked, state here whether this becomes a subgroup,
a sensitivity analysis, or a reason not to pool: ______________________
2. MODEL AND ESTIMATOR (decide before seeing results)
Model (fixed / random): ____________ Reason: ______________________
Between-study variance estimator: ______________________
Confidence interval method: ______________________
NOTE: do not choose the model on the basis of the observed
heterogeneity statistic.
3. WEIGHTS
Number of studies: ____ Heaviest single weight: ____%
[ ] Leave-one-out analysis planned, to be reported either way
[ ] Weight column will be shown in the forest plot
4. HETEROGENEITY REPORTING
[ ] Between-study variance reported, not only a ratio statistic
[ ] Prediction interval reported alongside the summary mean
[ ] Pre-specified subgroups listed, and labelled as observational
comparisons between studies
5. SMALL-STUDY EFFECTS
Number of studies: ____
[ ] If fewer than 10, NO funnel plot asymmetry test will be run
[ ] If 10 or more, test named, and a non-significant result will NOT
be reported as evidence against publication bias
6. NO-POOLING CONDITIONS (copy from protocol)
We will describe rather than pool if: ______________________
[ ] This rule was written before data extraction was complete Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.
How Pubrica can help
Pubrica’s biostatistics team specifies the model, the between-study variance estimator and the confidence-interval method at the protocol stage, so that the analysis is not selected after the result is known, and conducts the leave-one-out and prediction-interval analyses that make a pooled estimate interpretable. Where the included studies do not estimate the same quantity, Pubrica states this and assists in preparing a structured descriptive synthesis instead.